RxDoctor Payments Data

Donald Bragg

Urology · Homewood, ALNPI 1295789055

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Tolmar Pharmaceuticals, Inc. at 34.4% of the total. Reporting peaked in 2020 at $3,258 and has fallen 99.6% since, to $14 in 2023.

$7,626in general payments, 2019–2025

Across 197 payments — averaging $38.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar Pharmaceuticals, Inc.$3K
  • Neotract Inc.$1K
  • AbbVie$1K
  • Dendreon Pharmaceuticals LLC$751
  • Astellas Pharma US Inc$411
  • Urovant Sciences Inc$198
  • plus $1K from 23 others

What the payments were for

  • Consulting fees$5007%
  • Speaking & faculty fees$2,60034%
  • Travel & lodging$1,02713%
  • Food & beverage$3,20542%
  • Education$2944%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,626 in reported general payments places this provider in the 75th percentile of 179 urology providers in Alabama.

See all urology providers in Alabama

Other urology in Homewood

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →